Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: News
News
News Search  
If the Splice Is Right—BDNF to Dendrites, APP to Endosomes
11 July 2008. Alternative splicing of messenger RNAs can result in the production of protein isoforms with different functions, but why would a cell need alternative mRNAs that encode the same protein? The mRNA for brain-derived neurotrophic factor (BDNF), for example, exists in brain with two alternative 3’ untranslated regions, a short form and a long form. In today’s issue of Cell, Baoji Xu and colleagues from Georgetown University in Washington, DC, provide an explanation: the alternative mRNAs end up in different cellular locations, with the short form sent to the soma and the long form to dendrites. Dendritic BDNF, they show, has definite subcellular functions, controlling dendritic morphology and synaptic plasticity, both of which are affected in Alzheimer disease (AD).

Splicing that generates long and short protein isoforms is also implicated in AD by work that appears in the July 2 Journal of Biological Chemistry online. Sic Chan and colleagues at the University of Central Florida in Orlando report how different isoforms of the endocytic adaptor protein Numb have distinct effects on the trafficking and processing of the amyloid precursor protein (APP) and generation of amyloid-β in neurons. Importantly, the researchers suggest that the splicing of Numb is affected by cellular stress to result in the promotion of Aβ production. Together, the two studies demonstrate the role of splicing in regulating protein function in a way that is complex, barely understood, and potentially important for disease.

In the BDNF work, first authors Juan Ji An, Kusumika Gharami, and Guey-Ying Liao led the effort to determine whether the 3’ alternative splicing of BDNF, which has no effect on the protein coding region, was instead a way to target the message to soma versus dendrite. To do this, they first looked at localization of the splice forms and found the long form was preferentially located in dendrites in cultured rat cortical neurons. The long 3’ sequence was sufficient to target a green fluorescent protein reporter mRNA to dendrites, and that the message was translated there.

To follow up these findings in vivo, the researchers used a previously generated BDNF knock-in mouse that produces only a truncated 3’UTR message, and no long form. These mice have normal levels of total BDNF mRNA and protein, but the investigators found that cortical neurons cultured from the mice lack dendritic BDNF, and have less activity-stimulated BDNF release.

With no change in overall BDNF levels, the mutant mice offered a unique opportunity to explore the function of dendritic BDNF. When the researchers examined CA1 pyramidal neurons from young mice, they found the morphology of dendritic arbors looked normal, but the spines on distal dendrites were thinner and more numerous than in wild-type mice. Initial growth of spines was not affected in younger mice, but the lack of BDNF seemed to impair subsequent pruning and enlargement. The morphological changes had a functional counterpart, as the mutant mice displayed impairment of long-term potentiation at dendritic synapses, but not at somatic synapses.

While the study strongly implicates dendritically targeted BDNF in the normal formation and function of spines, the data beg the question of how BDNF acts. In their discussion, the authors favor an autocrine mechanism involving activation of the TrkB receptor. In addition, they point out that the strategy of using alternative 3’UTRs to target the same protein to different subcellular localization may not be unique to BDNF. The authors cite the calmodulin-stimulated kinase subunit CamKIIa as another mRNA that has the potential to be targeted this way (Blichenberg et al., 2001).

The second paper presents a variation on the splicing theme, where a switch in protein isoforms has the potential to affect APP processing. The protein in question is Numb, a putative endocytic adaptor protein that regulates processing of the γ-secretase substrate Notch. All four known human isoforms of Numb have been shown to associate with APP (Roncarati et al., 2002). In the new report, first author George Kyriazis and colleagues demonstrate that overexpression of a Numb isoform with a shorter PTB protein-protein interaction domain, but not one with a longer domain, leads to enhanced levels of APP protein in PC12 cells, and increased processing as indicated by accumulation of C-terminal fragments and Aβ. The accumulation of APP was not due to changes in APP mRNA or in activity of any of the secretases, but instead seemed to result from the isoform-specific targeting of APP to endosomes after its internalization from the plasma membrane. The alternative, longer isoform promoted APP delivery to lysosomes, and cells overexpressing the longer form had lower overall levels of APP and its products.

To support the physiological relevance of the Numb interaction, the researchers cultured primary cortical neurons under conditions of trophic factor withdrawal, and found that the expression of the short Numb isoform increased while the long form decreased, coincident with an increase in APP levels, and Aβ production. “Taken together, these results indicate that APP trafficking differs strikingly in the clones stably expressing the Numb proteins and raise the intriguing possibility that alternative splicing of Numb could alter the trafficking of APP and, concomitantly, its processing fate,” the authors conclude. In a previous paper, Chan and co-author Mark Mattson had shown that total Numb protein is increased in Aβ-containing regions in AD mouse brain (Chan et al., 2002). Chan told ARF in an e-mail that they are in the process of identifying those isoforms.—Pat McCaffrey.

References:
An JJ, Gharami K, Liao G-Y, Woo NH, Lau AG, Vanevski F, Torre ER, Jones KR, Feng Y, Lu B, Xu B. Distinct Role of Long 3’UTR BDNF mRNA in Spine Morphology and Synaptic Plasticity in Hippocampal Neurons. Cell. 2008 July 11; 134:175-187. Abstract

Kyriazis GA, Wei Z, Vandermey M, Jo DG, Xin O, Mattson MP, Chan SL. Numb endocytic adapter proteins regulate the transport and processing of the amyloid precursor protein in an isoform-dependent manner: implications for Alzheimer's disease pathogenesis. J Biol Chem. 2008 Jul 2. [Epub ahead of print] Abstract

 
Comments on News and Primary Papers
  Primary Papers: Distinct role of long 3' UTR BDNF mRNA in spine morphology and synaptic plasticity in hippocampal neurons.

Comment by:  Volkmar Lessmann
Submitted 26 July 2008  |  Permalink Posted 26 July 2008

The study by An and colleagues provides one of the first clues to an ongoing riddle. Why the already very complex pattern of multiple BDNF transcripts is further complicated by attaching the diverse mRNAs to two distinct polyadenylation signals. Making use of very elegant mouse models that were provided by colleagues in the field, the authors provide convincing evidence that mRNA versions with the longer 3'UTR are transported more efficiently into dendrites than those with the short 3'UTR tail.

Given that BDNF is an important mediator of activity-dependent synaptic plasticity, elucidating these subtle details of dendritic BDNF production and action are crucial to better understand the role of this growth factor in dementias such as Alzheimer disease. Several interesting questions arise from their important findings:

1. Data are required to show that regulated release of BDNF is affected selectively in dendrites and not in the soma, as the authors suggest.

2. The lack of dendritic BDNF protein surprisingly has a gain-of-function phenotype (increased number of dendritic...  Read more

  Submit a Comment on this News Article
Cast your vote and/or make a comment on this news article. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory:
*Login Email Address  
*Password    Minimum of 8 characters
*Confirm Password  
Stay signed in?  

I recommend the Primary Papers

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


*Enter the verification code you see in the picture below:


This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.
Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
ADNI Related Links
ADNI Data at LONI
ADNI Information
DIAN
Foundation for the NIH
AddNeuroMed
neuGRID
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad